{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:32:13Z","timestamp":1770485533630,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":920,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/mt.2013.282","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T17:27:11Z","timestamp":1386869231000},"page":"702-712","source":"Crossref","is-referenced-by-count":75,"title":["Sustained Correction of Motoneuron Histopathology Following Intramuscular Delivery of AAV in Pompe Mice"],"prefix":"10.1016","volume":"22","author":[{"given":"Mai K","family":"ElMallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin J","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushrusha","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland A","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milapjit S","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.282_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"Pompe disease and the respiratory system","volume":"189","author":"Fuller","year":"2013","journal-title":"Res Physiol Neurobiol"},{"issue":"R1","key":"10.1038\/mt.2013.282_bib2","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1093\/hmg\/ddr174","article-title":"Pompe disease gene therapy","volume":"20","author":"Byrne","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.282_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00455-009-9252-x","article-title":"Oropharyngeal dysphagia in infants and children with infantile Pompe disease","volume":"25","author":"Jones","year":"2010","journal-title":"Dysphagia"},{"key":"10.1038\/mt.2013.282_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.105.3.947","article-title":"Obstructive sleep apnea syndrome in acid maltase deficiency","volume":"105","author":"Margolis","year":"1994","journal-title":"Chest"},{"key":"10.1038\/mt.2013.282_bib5","first-page":"147","article-title":"Language and speech function in children with infantile Pompe disease","volume":"7","author":"Muller","year":"2009","journal-title":"J Ped Neurol"},{"key":"10.1038\/mt.2013.282_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mt.6300100","article-title":"Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors","volume":"15","author":"Mah","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.282_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.282_bib8","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/mt.2013.282_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/gt.2009.119","article-title":"Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6","volume":"17","author":"Towne","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.282_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2013.282_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/hgtb.2012.009","article-title":"Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9","volume":"23","author":"ElMallah","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mt.2013.282_bib12","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2013.282_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mus.22202","article-title":"Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation","volume":"44","author":"Dubrovsky","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1038\/mt.2013.282_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2012.12.003","article-title":"Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement","volume":"23","author":"Hobson-Webb","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/mt.2013.282_bib15","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"10.1038\/mt.2013.282_bib16","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2012.250","article-title":"Phase I\/II trial of AAV1-GAA gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes","author":"Smith","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2013.282_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/mt.2012.261","article-title":"Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice","volume":"21","author":"Benkhelifa-Ziyyat","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.282_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fphys.2011.00031","article-title":"Hypoglossal neuropathology and respiratory activity in pompe mice","volume":"2","author":"Lee","year":"2011","journal-title":"Front Physiol"},{"issue":"suppl 2","key":"10.1038\/mt.2013.282_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etp.2006.02.014","article-title":"Further exploration of the Penh parameter","volume":"57","author":"Lomask","year":"2006","journal-title":"Exp Toxicol Pathol"},{"key":"10.1038\/mt.2013.282_bib20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1038\/mt.2013.282_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2013.282_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","article-title":"Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration","volume":"14","author":"Bostick","year":"2007","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.282_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2013.282_bib24","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/mt.2008.73","article-title":"Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice","volume":"16","author":"Towne","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.282_bib25","doi-asserted-by":"crossref","first-page":"e64755","DOI":"10.1371\/journal.pone.0064755","article-title":"Targeted delivery of TrkB receptor to phrenic motoneurons enhances functional recovery of rhythmic phrenic activity after cervical spinal hemisection","volume":"8","author":"Gransee","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2013.282_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2013.282_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/hum.2011.200","article-title":"AAV9 transduction in the central nervous system of non-human primates","volume":"23","author":"Samaranch","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2013.282_bib28","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.282_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/hum.2011.200","article-title":"Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates","volume":"23","author":"Samaranch","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2013.282_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mt.2009.15","article-title":"AAV9: a potential blood-brain barrier buster","volume":"17","author":"Manfredsson","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.282_bib31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.gt.3302550","article-title":"Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors","volume":"12","author":"Mah","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.282_bib32","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"10.1038\/mt.2013.282_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2013.282_bib34","first-page":"379","article-title":"Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings","volume":"27","author":"Teng","year":"2004","journal-title":"Chang Gung Med J"},{"key":"10.1038\/mt.2013.282_bib35","first-page":"1388","article-title":"Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease","volume":"142","author":"Willemsen","year":"1998","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1038\/mt.2013.282_bib36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005072-197107000-00008","article-title":"Nervous system in Pompe's disease. Ultrastructure and biochemistry","volume":"30","author":"Gambetti","year":"1971","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2013.282_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10545-010-9075-9","article-title":"Pathophysiology of neuropathic lysosomal storage disorders","volume":"33","author":"Bellettato","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2013.282_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1038\/mt.2013.282_bib39","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1089\/10430349950017158","article-title":"Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene","volume":"10","author":"Hartung","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2013.282_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exnr.1999.7176","article-title":"Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice","volume":"160","author":"Skorupa","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2013.282_bib41","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/sj.mt.6300227","article-title":"Time course of transgene expression after intrastriatal pseudotyped rAAV2\/1, rAAV2\/2, rAAV2\/5, and rAAV2\/8 transduction in the rat","volume":"15","author":"Reimsnider","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.282_bib42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-010-9206-3","article-title":"Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience","volume":"33","author":"Chakrapani","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2013.282_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","article-title":"Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy","volume":"35","author":"van Gelder","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2013.282_bib44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10545-010-9209-0","article-title":"CRIM-negative infantile Pompe disease: 42-month treatment outcome","volume":"33","author":"Rohrbach","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2013.282_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-0102(02)00195-5","article-title":"Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport","volume":"45","author":"Lu","year":"2003","journal-title":"Neurosci Res"},{"key":"10.1038\/mt.2013.282_bib46","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1152\/japplphysiol.00815.2002","article-title":"Interpreting Penh in mice","volume":"94","author":"Mitzner","year":"2003","journal-title":"J Appl Physiol (1985)"},{"key":"10.1038\/mt.2013.282_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00455-009-9252-x","article-title":"Oropharyngeal dysphagia in infants and children with infantile Pompe disease","volume":"25","author":"Jones","year":"2010","journal-title":"Dysphagia"},{"key":"10.1038\/mt.2013.282_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"},{"key":"10.1038\/mt.2013.282_bib49","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ilar.47.4.364","article-title":"Establishing an appropriate period of acclimatization following transportation of laboratory animals","volume":"47","author":"Obernier","year":"2006","journal-title":"ILAR J"},{"key":"10.1038\/mt.2013.282_bib50","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jpeds.2013.03.002","article-title":"B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease","volume":"163","author":"Elder","year":"2013","journal-title":"J Pediatr"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616311972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616311972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T21:01:47Z","timestamp":1564952507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616311972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1525001616311972"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.282","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}